Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HLA class II DP beta 1*04 peptide–receptor complex is a cell-surface receptor composed of two subunits (DPα and DPβ, the latter encoded by the HLA-DPB1*04 allele), forming part of the major histocompatibility complex (MHC) class II pathway on human chromosome 6. This complex binds and displays extracellularly derived peptides on the surface of antigen-presenting cells such as dendritic cells, macrophages, and B cells for recognition by CD4+ T lymphocytes, initiating and regulating adaptive immune responses. HLA-DPB1*04:01 variants influence susceptibility to certain autoimmune diseases (notably granulomatosis with polyangiitis), can modulate responses to infections and cancer, and are important in transplantation medicine for matching donor and recipient compatibility. Novel structural studies reveal that this particular complex can bind peptides in both conventional and reverse orientations, broadening the repertoire of T cell responses.
Presentation of extracellular peptide antigens to CD4+ T cells, triggering adaptive immune activation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA class II DP beta 1*04 peptide–receptor complex (HLA-DPB1*04:01 complex).